Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 98,400 shares at $8.95 ($881K) on 2025-05-01, disclosed to the SEC on 2025-05-05.
Scheduled sale ($881k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.95 | 21,864 | $196K | 22.2% |
| 2 | $8.95 | 21,864 | $196K | 22.2% |
| 3 | $8.95 | 27,336 | $245K | 27.8% |
| 4 | $8.95 | 27,336 | $245K | 27.8% |
| Total | $8.95 avg | 98,400 | $881K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |
| VRNA | SELL | 2024-11-26 | $1.2M | — | Filing → |